Anti-B7-H1, Mouse, Goat-Poly

データシート※最新のデータシートでない場合があります

• 商品コード：AF1019
• メーカー：RSD
• 包装：100μg
• 価格： ¥105,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Wang J et al. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(33):11823-8
  Wang J et al
  2005/01/01
  
• 備考：
  Application: IHC Fresh, Sample Type: Whole Cells
• 参照：
  

• No.： 2
• 文献情報：
  Dal Secco V et al. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma. Biol. Reprod. 2008 Feb;78(2):234-42
  Dal Secco V et al
  2008/01/01
  
• 備考：
  Species: Mouse, Application: Western Blot, Homogenized Tissue
• 参照：
  

• No.： 3
• 文献情報：
  Yadav D et al. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. Cell. Immunol. 2009;258(2):161-71
  Yadav D et al
  2009/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 4
• 文献情報：
  Kasagi S et al. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice. J. Immunol. 2010 Mar;184(5):2337-47
  Kasagi S et al
  2010/01/01
  
• 備考：
  Application: IHC Frozen, Sample Type: Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Duncan FJ et al. Endogenous retinoids in the pathogenesis of alopecia areata. J. Invest. Dermatol. 2013 Feb;133(2):334-43
  Duncan FJ et al
  2013/01/01
  
• 備考：
  Application: IHC - Not specified, Sample Type: tissue
• 参照：
  

• No.： 6
• 文献情報：
  Cao Y et al. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells. Br. J. Haematol. 2015 Mar;168(5):701-7
  Cao Y et al
  2015/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 7
• 文献情報：
  Abiko K et al. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br. J. Cancer 2015 Apr;112(9):1501-9
  Abiko K et al
  2015/01/01
  
• 備考：
  Application: IHC - Not specified,Western Blot, Sample Type: Homogenized Tissue,Whole Tissue
• 参照：
  

• No.： 8
• 文献情報：
  El Khatib MM et al. β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection. Gene Ther. 2015 May;22(5):430-8
  El Khatib MM et al
  2015/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 9
• 文献情報：
  Seifert AM et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin. Cancer Res. 2016 Jul;
  Seifert AM et al
  2016/01/01
  
• 備考：
  Application: IHC - Paraffin embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 10
• 文献情報：
  Mascia F et al. Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas. Int. J. Cancer 2016 Dec;139(11):2593-7
  Mascia F et al
  2016/01/01
  
• 備考：
  Application: IHC - Paraffin embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 11
• 文献情報：
  Sung SJ et al. Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice. J. Immunol. 2017 Apr;198(7):2589-2601
  Sung SJ et al
  2017/01/01
  
• 備考：
  Application: Flow Cytometry,IHC, Sample Type: Whole Cells,Whole Tissue
• 参照：
  

• No.： 12
• 文献情報：
  Bartee MY et al. Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy. Cancer Res. 2017 Jun;77(11):2952-2963
  Bartee MY et al
  2017/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 13
• 文献情報：
  Osum KC et al. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes. Sci Rep 2018 May;8(1):8295
  Osum KC et al
  2018/01/01
  
• 備考：
  Species: Mouse, Applications: IHC
• 参照：
  

• No.： 14
• 文献情報：
  Dimitrov V et al. Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice. J. Biol. Chem. 2017 Dec;292(50):20657-20668
  Dimitrov V et al
  2017/01/01
  
• 備考：
  Species: Human, Applications: WB
• 参照：
  

• No.： 15
• 文献情報：
  Srinivasan P et al. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease. PLoS Med. 2018 Jan;15(1):e1002497
  Srinivasan P et al
  2018/01/01
  
• 備考：
  Species: Mouse, Applications: IHC-P
• 参照：
  

• No.： 16
• 文献情報：
  Schreiber LM et al. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. Br J Cancer 2019 10;121(8):647-658
  Schreiber LM et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Ritzmann F et al. IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer. Sci Rep 2019 07;9(1):10353
  Ritzmann F et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Philippou Y et al. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model. Br J Cancer 2020 09;123(7):1089-1100
  Philippou Y et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 19
• 文献情報：
  Fernandes RA et al. Immune receptor inhibition through enforced phosphatase recruitment. Nature 2020 10;586(7831):779-784
  Fernandes RA et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: Flow Cytometry
• 参照：
  

• No.： 20
• 文献情報：
  Lerbs T et al. CD47 prevents the elimination of diseased fibroblasts in scleroderma. JCI Insight 2020 08;5(16)
  Lerbs T et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: ICC
• 参照：